000 | 01971 a2200493 4500 | ||
---|---|---|---|
005 | 20250515144809.0 | ||
264 | 0 | _c20090130 | |
008 | 200901s 0 0 eng d | ||
022 | _a1460-9568 | ||
024 | 7 |
_a10.1111/j.1460-9568.2008.06423.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCollo, Ginetta | |
245 | 0 | 0 |
_aDopamine D3 receptor-preferring agonists increase dendrite arborization of mesencephalic dopaminergic neurons via extracellular signal-regulated kinase phosphorylation. _h[electronic resource] |
260 |
_bThe European journal of neuroscience _cOct 2008 |
||
300 |
_a1231-40 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAmphetamine _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCell Shape _xdrug effects |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aDendrites _xdrug effects |
650 | 0 | 4 |
_aDopamine _xmetabolism |
650 | 0 | 4 |
_aDopamine Agonists _xpharmacology |
650 | 0 | 4 |
_aDopamine Antagonists _xpharmacology |
650 | 0 | 4 | _aDopamine D2 Receptor Antagonists |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 |
_aExtracellular Signal-Regulated MAP Kinases _xantagonists & inhibitors |
650 | 0 | 4 |
_aMesencephalon _xcytology |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aNerve Growth Factors _xpharmacology |
650 | 0 | 4 |
_aNeurogenesis _xdrug effects |
650 | 0 | 4 |
_aQuinpirole _xpharmacology |
650 | 0 | 4 |
_aReceptors, Dopamine D2 _xagonists |
650 | 0 | 4 |
_aReceptors, Dopamine D3 _xagonists |
650 | 0 | 4 |
_aSubstantia Nigra _xcytology |
650 | 0 | 4 |
_aTetrahydronaphthalenes _xpharmacology |
650 | 0 | 4 |
_aTyrosine 3-Monooxygenase _xmetabolism |
700 | 1 | _aZanetti, Silvia | |
700 | 1 | _aMissale, Cristina | |
700 | 1 | _aSpano, Pierfranco | |
773 | 0 |
_tThe European journal of neuroscience _gvol. 28 _gno. 7 _gp. 1231-40 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1460-9568.2008.06423.x _zAvailable from publisher's website |
999 |
_c18435427 _d18435427 |